Antibody Research
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
15
NCT04396717
Safety Study of Pritumumab in Brain Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 22, 2021
Completion: Jan 6, 2023
Loading map...